Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: a gender-specific follow-up study

Atherosclerosis
Marit SolbuIngrid Toft

Abstract

Increased urinary albumin-excretion (UAE) predicts cardiovascular events and clusters with the metabolic syndrome. The aim of this population-based, prospective study was to assess the relationship between baseline and longitudinal changes in cardiovascular risk-factors and 7 years' increase in UAE. Three thousand and four hundred non-diabetic participants (1838 men, 1562 women) of the Tromsø studies in 1994/1995 and 2001/2002 were included. In each survey, first-void spot-urine-samples were collected, and albumin-creatinine ratio (ACR) was calculated. Change in ACR (DeltaACR) was dichotomized into upper vs. the three lower quartiles. Median UAE in the population did not increase during follow-up. Baseline predictors for DeltaACR in the upper quartile were: age (OR 1.32 per 5 years, 95% CI 1.22-1.43), HbA1c (OR 1.43 per %, 95% CI 1.08-1.91) and waist circumference (OR 1.11 per 5 cm, 95% CI 1.04-1.19) in men, and age (OR 1.14 per 5 years, 95% CI 1.04-1.25) and current smoking (OR 1.71, 95% CI 1.27-2.30) in women. Systolic blood pressure and estimated glomerular filtration rate were predictors without gender-specificity. Clustering of three or more metabolic traits did not predict ACR increase independently. Protective factors ag...Continue Reading

References

Feb 9, 1984·The New England Journal of Medicine·C E Mogensen
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Mar 20, 2003·Current Diabetes Reports·Kevin RowleyJames D Best
Apr 23, 2003·Journal of the American Society of Nephrology : JASN·Jacobien C VerhaveUNKNOWN PREVEND Study Group
Apr 23, 2003·Journal of the American Society of Nephrology : JASN·Eberhard Ritz
May 20, 2005·Journal of the American Society of Nephrology : JASN·Manjula KurellaGlenn M Chertow
Sep 27, 2005·Lancet·K George M M AlbertiUNKNOWN IDF Epidemiology Task Force Consensus Group
Jan 12, 2007·Journal of the American Society of Nephrology : JASN·Auke H BrantsmaRonald T Gansevoort
Mar 3, 2007·Clinical Chemistry·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Mar 9, 2007·Journal of the American Society of Nephrology : JASN·Anna KottgenJosef Coresh
Mar 16, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Aminu K BelloRonald T Gansevoort

❮ Previous
Next ❯

Citations

May 19, 2010·European Journal of Applied Physiology·Beth A ParkerDavid N Proctor
Oct 28, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·L GilardiniC Invitti
Aug 25, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Toralf MelsomBjørn O Eriksen
Dec 17, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Jørgen ScheiToralf Melsom
Jun 7, 2015·Journal of the American Society of Nephrology : JASN·Marit D SolbuTrond G Jenssen
Jan 9, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Toralf MelsomBjørn Odvar Eriksen
Jul 6, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Conall M O'SeaghdhaCaroline S Fox
Jul 14, 2010·Cardiology Clinics·Adam T Whaley-Connell, Rigas G Kalaitzidis
Sep 30, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Toralf MelsomBjørn O Eriksen
Jan 16, 2019·Journal of Cellular Biochemistry·Manju KumariSwasti Tiwari
Feb 6, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Jørgen ScheiToralf Melsom
May 30, 2020·International Journal of Environmental Research and Public Health·Mohammed Al-BouwarthanDavid H Wegman
Oct 26, 2018·Hypertension·Bjørn O EriksenToralf Melsom
Mar 2, 2017·BMC Nephrology·Bjørn O EriksenToralf Melsom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.